Challenges to Developing and Implementing Integrated Pain Management Programs
DCRI faculty recently contributed to a paper advocating for a focus on pain management so that progress in combatting the U.S. opioid crisis is not lost in the midst of the COVID-19 pandemic.
Splanchnic Nerve Block Effective for Improving Exercise Measures in Patients with Heart Failure
Recent study results showed that a novel potential therapy for heart failure was effective during exercise, building on an earlier study that showed its effectiveness at rest.
DCRI Study Provides Insight into Re-operation After Transcatheter Valve Replacement
Although valve failure is rare, patients who had to undergo re-operation were at risk of negative outcomes.
Editorial Shares Takeaways from Recent Deprescribing Study
The DCRI’s Eric Peterson, MD, MHS, recently reviewed an important study in JAMA examining novel strategies to de-escalate hypertension treatment in older adults.
DCRI Studies Lead To Greater Knowledge about Video Gaming as an ADHD Treatment
In a first-of-its-kind decision, the FDA has approved a video game as a prescribed treatment for children with ADHD.
Hernandez Talks HCQ Retractions, HERO Research
The Rise of Telehealth During COVID-19
PTN, CTTI Partner on Study, Identify Risk Factors for Hospital-Acquired Pneumonia
The study team used pediatric patients’ electronic health records to identify patients eligible for the study.
DCRI Cardiologists Help to Define Care Pathway for Patients with COVID-19
In response to a wide array of cardiovascular complications seen in patients with COVID-19, the Duke Health system has developed a framework which organizes its approach to caring for patients with
DCRI to Partner with Boehringer Ingelheim and Eli Lilly on new Pragmatic Trial
The indication-seeking trial is the first in the SGLT2 inhibitor class to investigate whether empagliflozin can be used to prevent heart failure after a heart attack.